Medication regimen complexity and readmissions after hospitalization for heart failure, acute myocardial infarction, pneumonia, and chronic obstructive pulmonary disease

被引:25
|
作者
Abou-Karam, Nada [1 ,2 ]
Bradford, Chad [1 ,2 ]
Lor, Kajua B. [2 ]
Barnett, Mitchell [2 ]
Ha, Michelle [3 ]
Rizos, Albert [4 ]
机构
[1] Sharp Mem Hosp & Rehabil Ctr, Dept Pharm Serv, 7901 Frost St, San Diego, CA 92123 USA
[2] Touro Univ Calif, Dept Clin Sci, Coll Pharm, Vallejo, CA USA
[3] Western Univ Hlth Sci, Coll Pharm, Pomona, CA USA
[4] Sharp Healthcare, Syst Pharm Serv, San Diego, CA USA
来源
SAGE OPEN MEDICINE | 2016年 / 4卷
关键词
Medication regimen complexity index; readmission; re-hospitalization; acute care utilization; high-risk disease state;
D O I
10.1177/2050312116632426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Readmission rate is increasingly being viewed as a key indicator of health system performance. Medication regimen complexity index scores may be predictive of readmissions; however, few studies have examined this potential association. The primary objective of this study was to determine whether medication regimen complexity index is associated with all-cause 30-day readmission after admission for heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease. Methods: This study was an institutional review board-approved, multi-center, case-control study. Patients admitted with a primary diagnosis of heart failure, acute myocardial infarction, pneumonia, or chronic obstructive pulmonary disease were randomly selected for inclusion. Patients were excluded if they discharged against medical advice or expired during their index visit. Block randomization was utilized for equal representation of index diagnosis and site. Discharge medication regimen complexity index scores were compared between subjects with readmission versus those without. Medication regimen complexity index score was then used as a predictor in logistic regression modeling for readmission. Results: Seven hundred and fifty-six patients were randomly selected for inclusion, and 101 (13.4%) readmitted within 30 days. The readmission group had higher medication regimen complexity index scores than the no-readmission group (p < 0.01). However, after controlling for demographics, disease state, length of stay, site, and medication count, medication regimen complexity index was no longer a significant predictor of readmission (odds ratio 0.99, 95% confidence interval 0.97-1.01) or revisit (odds ratio 0.99, 95% confidence interval 0.98-1.02). Conclusion: There is little evidence to support the use of medication regimen complexity index in readmission prediction when other measures are available. Medication regimen complexity index may lack sufficient sensitivity to capture an effect of medication regimen complexity on all-cause readmission.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Chronic Obstructive Pulmonary Disease and Heart Failure
    Villar Alvarez, Felipe
    Mendez Bailon, Manuel
    de Miguel Diez, Javier
    ARCHIVOS DE BRONCONEUMOLOGIA, 2009, 45 (08): : 387 - 393
  • [32] Heart Failure and Chronic Obstructive Pulmonary Disease
    Hawkins, Nathaniel M.
    Petrie, Mark C.
    MacDonald, Michael R.
    Jhund, Pardeep S.
    Fabbri, Leonardo M.
    Wikstrand, John
    McMurray, John J. V.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (21) : 2127 - 2138
  • [33] Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
    Ko, Dennis T.
    Khera, Rohan
    Lau, Geoffrey
    Qiu, Feng
    Wang, Yongfei
    Austin, Peter C.
    Koh, Maria
    Lin, Zhenqiu
    Lee, Douglas S.
    Wijeysundera, Harindra C.
    Krumholz, Harlan M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (07) : 736 - 746
  • [34] Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
    Andell, P.
    Koul, S.
    Martinsson, A.
    Lindahl, B.
    Erlinge, D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 664 - 664
  • [35] Myocardial Infarction and Ischemic Stroke after Exacerbations of Chronic Obstructive Pulmonary Disease
    Rothnie, Kieran J.
    Connell, Olivia
    Mullerova, Hana
    Smeeth, Liam
    Pearce, Neil
    Douglas, Ian
    Quint, Jennifer K.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15 (08) : 935 - 946
  • [36] Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction
    Andell, Pontus
    Koul, Sasha
    Martinsson, Andreas
    Sundstrom, Johan
    Jernberg, Tomas
    Smith, J. Gustav
    James, Stefan
    Lindahl, Bertil
    Erlinge, David
    OPEN HEART, 2014, 1 (01):
  • [37] Acute heart failure after myocardial infarction
    Macic-Dzankovic, Amra
    Pojskic, Belma
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2007, 7 (01) : 40 - 47
  • [38] Risk of exacerbation following pneumonia in adults with heart failure or chronic obstructive pulmonary disease
    Bornheimer, Rebecca
    Shea, Kimberly M.
    Sato, Reiko
    Weycker, Derek
    Pelton, Stephen I.
    PLOS ONE, 2017, 12 (10):
  • [39] The role of pulmonary hypertension in the development of heart failure after acute myocardial infarction
    Aronson, D.
    Mutlak, D.
    Hammerman, H.
    Agmon, Y.
    EUROPEAN HEART JOURNAL, 2010, 31 : 284 - 284
  • [40] Characteristics of Patients With Congestive Heart Failure or Chronic Obstructive Pulmonary Disease Readmissions Within 30 Days Following an Acute Exacerbation
    Castillo, Austin
    Edriss, Hawa
    Selvan, Kavitha
    Nugent, Kenneth
    QUALITY MANAGEMENT IN HEALTH CARE, 2017, 26 (03) : 152 - 159